- Home
- CSCO vs ABBV Comparison
CSCO vs ABBV Comparison
Compare CSCO & ABBV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CSCO | ABBV |
|---|---|---|
| Founded | 1984 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Communications Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 440.5B | 358.5B |
| IPO Year | 2003 | 2012 |
Fundamental Metrics
Financial Performance| Metric | CSCO | ABBV |
|---|---|---|
| Price | $114.17 | $259.22 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 16 | 18 |
| Target Price | $89.80 | ★ $253.71 |
| AVG Volume (30 Days) | ★ 20.0M | 4.5M |
| Earning Date | 05-13-2026 | 04-29-2026 |
| Dividend Yield | 1.88% | ★ 3.39% |
| EPS Growth | ★ 0.39 | N/A |
| EPS | ★ 2.36 | 0.39 |
| Revenue | $49,330,000,000.00 | ★ $61,160,000,000.00 |
| Revenue This Year | $10.86 | $11.87 |
| Revenue Next Year | $4.60 | $8.12 |
| P/E Ratio | ★ $47.78 | $658.46 |
| Revenue Growth | 2.76 | ★ 8.57 |
| 52 Week Low | $65.80 | $187.62 |
| 52 Week High | $130.37 | $261.64 |
Technical Indicators
Market Signals| Indicator | CSCO | ABBV |
|---|---|---|
| Relative Strength Index (RSI) | 47.53 | 65.69 |
| Support Level | $74.24 | $220.72 |
| Resistance Level | $122.25 | $261.30 |
| Average True Range (ATR) | 3.39 | 5.55 |
| MACD | -0.37 | -0.41 |
| Stochastic Oscillator | 41.19 | 89.77 |
Price Performance
Historical ComparisonAbout CSCO Cisco Systems Inc. (DE)
Cisco Systems is the largest provider of networking equipment in the world and one of the largest software companies in the world. Its largest businesses are selling networking hardware and software (where it has leading market shares) and cybersecurity software such as firewalls. It also has collaboration products, like its Webex suite, and observability tools. It primarily outsources its manufacturing to third parties and has a large sales and marketing staff—25,000 strong across 90 countries. Overall, Cisco employs 80,000 people and sells its products globally.
About ABBV AbbVie Inc.
AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics, including Botox. The 2024 acquisitions of Cerevel (neuroscience) and ImmunoGen (oncology) help supplement AbbVie's portfolio.